Rascas 1.5mg Injection

Discover how Rascas 1.5mg Injection, formulated by Sayre Therapeutics Pvt Ltd with Rasburicase (1.5mg), can assist with Treatment of High uric acid due to chemotherapy. This page provides a comprehensive overview of this medication, including its primary applications and further detailed information to support your understanding. Feel free to add it to your favorites or compare it with other available options.

MRP: ₹ 10560
Packing: 1.0 Injection in 1 vial
Salt Combination: Rasburicase (1.5mg)
Brand: Sayre Therapeutics Pvt Ltd
Uses: Treatment of High uric acid due to chemotherapy

Description

Rascas 1.5mg Injection is used in the treatment of high uric acid due to chemotherapy
It lowers uric acid levels in the blood which helps prevent kidney damage in cancer patients
It is given as a slow injection into veins by a doctor or a nurse
Your doctor will decide what dose is necessary and how often you need to take it
This will depend on what you are being treated for and may change from time to time
You should take it exactly as your doctor has advised
Taking it in the wrong way or taking too much can cause very serious side effects
It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, headache, vomiting, and rash
However, some side effects require immediate action, hence inform your doctor if you experience difficulty in breathing, chest pain, swelling in the face and throat, itching, or dizziness after taking this medicine
Your doctor may get regular blood tests to check the levels of uric acid during treatment with this medicine
It is better to take plenty of fluids to avoid dehydration.
Many other medicines can affect, or be affected by, this medicine so let your doctor know about all the medications you are using
Let your doctor also know if you have any preexisting medical conditions to make sure this medicine is safe for you.

Cautions

Liver:	SAFE IF PRESCRIBED: Rascas 1.5mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Rascas 1.5mg Injection may not be needed in these patients. Please consult your doctor.
Kidney:	SAFE IF PRESCRIBED: Rascas 1.5mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Rascas 1.5mg Injection may not be needed in these patients. Please consult your doctor.
Driving:	CONSULT YOUR DOCTOR: It is not known whether Rascas 1.5mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Breast feeding:	SAFE IF PRESCRIBED: Rascas 1.5mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnency:	CONSULT YOUR DOCTOR: Rascas 1.5mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol:	CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Rascas 1.5mg Injection. Please consult your doctor.
Drug Action:	Uricolytic agent- Chemotherapy
Therapeutic class:	BLOOD RELATED
Habit Forming:	No
Chemical Class:	Recombinant Xanthine Oxidase Enzyme

Uses of Rascas 1.5mg Injection

In Treatment of High uric acid due to chemotherapy Certain types of cancer, like kidney or bladder cancer, may cause high levels of uric acid due to ongoing cancer chemotherapy
This can worsen patient health conditions and also lead to more serious health issues
Rascas 1.5mg Injection helps reduce these high levels of uric acid and prevents further complications
This will ensure speedy recovery and improve your quality of life
Follow your doctor’s instructions and let your doctor know if you have any concerns.